Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome

Two infants with retinoblastoma and 13q syndrome with multiorgan system anomalies were treated with targeted intra-arterial chemotherapy (IAC) using one-to-three cycles of melphalan 5 mg to avoid systemic chemotherapeutic side effects. Both patients showed good response, with tumor control and no sy...

Full description

Saved in:
Bibliographic Details
Published in:Oman J Ophthalmol
Main Authors: Dillon, Alexander B., Douglass, Alexzandra, Jabbour, Pascal, Shields, Carol L.
Format: Artigo
Language:Inglês
Published: Medknow Publications & Media Pvt Ltd 2016
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084500/
https://ncbi.nlm.nih.gov/pubmed/27843232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-620X.192278
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items